Board of Trustees Committee Charters

Mayo Clinic Board of Governors

The Mayo Clinic Board of Governors functions as the executive committee of the Board of Trustees and has all of the powers of the Board of Trustees which may arise between meetings of the trustees.

  • John H. Noseworthy, M.D., Chair
  • Daniel J. Berry, M.D.
  • Jeffrey W. Bolton, Secretary
  • Steven J. Buskirk, M.D.
  • Wyatt W. Decker, M.D.
  • Bobbie S. Gostout, M.D.
  • Eddie L. Greene, M.D.
  • Charles (Michel) M. Harper, Jr., M.D.
  • Pamela O. Johnson
  • Lois E. Krahn, M.D.
  • Dawn S. Milliner, M.D.
  • Veronique L. Roger, M.D.
  • William C. Rupp, M.D.
  • Mary J. (Mary Jo) Williamson
  • John H. Weston, Assistant Secretary

Governance and Management Structure (PDF)

Audit and Compliance Committee

The Audit and Compliance Committee has the power to select, engage, discharge, and approve compensation arrangements with independent accountants to audit the books and records of the Corporation and oversees the accounting and financial reporting processes of Mayo Clinic and the audit of the financial statements of Mayo Clinic.

  • Charles B. (Charlie) Tomm, Chair
  • Linda G. Alvarado
  • Bradbury H. (Brad) Anderson
  • Samuel A. DiPiazza Jr.
  • Roy A. Herberger Jr., Ph.D.
  • Kedrick D. Adkins*
  • Jeffrey W. Bolton*
  • Heather A. Byrne, Co-Secretary*
  • Chris W. Gade*
  • Carrie L. Graunke, Co-Secretary*
  • Roger A. Lindahl*
  • Joshua B. Murphy*
  • Mary I. O’Connor, M.D.*
  • Kimberly K. Otte*
  • Jonathan J. Oviatt*
  • Darrell L. Sandeen*

Audit and Compliance Committee Charter (Word document)

* = Non-member, ex-officio or staff

Business Development Committee

The role of the Business Development Committee is to: maintain responsibility for oversight and guidance for Mayo Clinic's business initiatives that extend Mayo Clinic's clinical, research, educational and administrative knowledge and capabilities beyond the traditional delivery models for patient care, research and education. In addition to monitoring the performance and strategy for Mayo Clinic's portfolio of business activities that are extensions of the core business, the Committee will be responsible for review and endorsement of new business initiatives that meet one of the following criteria: require institutional investment of more than $5 million or debt financing; or involve new or particularly high-profile use of Mayo Clinic's brand.

  • Roy A. Herberger Jr., Ph.D., Chair
  • Randolph C. Steer, M.D., Ph.D., Vice Chair
  • Linda Alvarado
  • Daniel J. Berry, M.D.
  • Jeffrey W. Bolton
  • Wyatt W. Decker, M.D.
  • Samuel A. Di Piazza Jr.
  • William W. (Bill) George
  • Bobbie S. Gostout, M.D.
  • George C. Halvorson
  • Charles (Michel) M. Harper, Jr., M.D.
  • Pamela O. Johnson
  • Dawn S. Milliner, M.D.
  • John H. Noseworthy, M.D.
  • Ronald L. Olson
  • Michael K. Powell
  • Charles B. (Charlie) Tomm
  • Mary J. (Mary Jo) Williamson
  • Jade R. Sadosty, Secretary*
  • Chris W. Gade*
  • Gregory J. Gores, M.D.*
  • Jonathan J. Oviatt*

* = Non-member, ex-officio or staff

Business Development Committee Charter (PDF)

Development Committee and Campaign Executive Committee

The Development Committee shall review and make recommendations to the Board of Trustees regarding development policies, strategies and practices of Mayo Clinic.

  • Bradbury H. (Brad) Anderson, Co-Chair
  • James L. Barksdale, Co-Chair
  • Jeffrey W. Bolton
  • Thomas J. (Tom) Brokaw
  • Michael Camilleri, M.D.
  • Mary Sue Coleman, Ph.D.
  • Wyatt W. Decker, M.D.
  • Michael E. Dougherty
  • Charles (Michel) M. Harper, Jr., M.D.
  • John H. Noseworthy, M.D.
  • Veronique L. Roger, M.D.
  • William C. Rupp, M.D.
  • Charles B. (Charlie) Tomm
  • Cheryl J. Hadaway, Secretary*
  • Kedrick D. Adkins, Jr.*
  • Samuel A. Di Piazza, Jr.*
  • Danny R. and Eunice C. Carmichael*
  • A. Dano Davis*
  • Chris W. Gade*
  • Louis L. Gonda*
  • Gregory J. Gores, M.D.*
  • George M. Lund*
  • Marilyn Carlson Nelson*
  • J. W. Marriott, Jr.*
  • Robert E. Nesse, M.D.*
  • Carla Paonessa*
  • Anne M. Tatlock*

* = Non-member, ex-officio or staff

Development Committee Charter (PDF)

Finance Committee

The Finance Committee reviews and makes recommendations to the full Board of Trustees regarding the business policies, strategies and practices of Mayo Clinic.

  • William (Bill) W. George, Chair
  • Daniel J. Berry, M.D.
  • Steven J. Buskirk, M.D.
  • Mary Sue Coleman, Ph.D.
  • Wyatt W. Decker, M.D.
  • Eddie L. Greene, M.D.
  • Charles (Michel) M. Harper, Jr., M.D.
  • Roy A. Herberger, Jr., Ph.D.
  • John H. Noseworthy, M.D.
  • Ronald L. Olson
  • William C. Rupp, M.D.
  • Diana L. Taylor
  • Charles B. (Charlie) Tomm
  • Kedrick D. Adkins, Jr., Secretary*
  • Jeffrey W. Bolton*
  • Samuel A. Di Piazza Jr., ex-officio*
  • Chris W. Gade*

* = Non-member, ex-officio or staff

Finance Committee Charter (PDF)

Governance and Nominating Committee

The Governance Committee approves compensation policies, salaries and other forms of compensation paid to all Internal Members of the Board of Trustees and to Officers of Mayo Clinic, and compensation policies and salary ranges applicable to all physicians (excluding physicians in resident training programs) and senior administrators employed by Mayo Clinic and its tax-exempt subsidiaries. The Committee's role is to confirm the overall reasonableness of Mayo Clinic compensation policies based upon current and relevant benchmark information and based upon recommendations of consultants, the Mayo Clinic Salary and Benefits Committee, and Mayo Clinic Salary Administration.

  • Samuel A. Di Piazza Jr., Chair
  • Thomas J. (Tom) Brokaw, Vice Chair
  • Bradbury H. (Brad) Anderson
  • Michael E. Dougherty
  • William (Bill) W. George
  • Roy A. Herberger Jr., Ph.D.
  • Aulana L. Peters
  • Michael K. Powell
  • Charles B. (Charlie) Tomm
  • Jonathan J. Oviatt, Secretary*
  • Jeffrey W. Bolton*
  • Chris W. Gade*
  • John H. Noseworthy, M.D.*
  • Jonathan J. Oviatt, Secretary*

* = Non-member, ex-officio or staff

Governance and Nominating Committee Charter (PDF)

Information Management & Technology Oversight Committee

The Information Management & Technology Oversight Committee reviews and makes recommendations to the full Board of Trustees regarding the investment policies, strategies and practices of Mayo Clinic.

  • Michael K. Powell, Chair
  • Jeffrey W. Bolton
  • Armando Codina
  • Samuel A. Di Piazza Jr.
  • Bobbie S. Gostout, M.D.
  • George Halvorson
  • Pamela O. Johnson
  • Lois E. Krahn, M.D.
  • Dawn S. Milliner, M.D.
  • Aulana L. Peters
  • Veronique L. Roger, M.D.
  • Eric E. Schmidt, Ph.D.
  • Randolph C. Steer, Ph.D.
  • Mary Jo Williamson
  • Christopher J. Ross, Assistant Secretary*
  • Chris W. Gade*
  • John H. Noseworthy, M.D.*

* = Non-member, ex-officio or staff

Information Management and Technology Oversight Committee Charter (PDF)

Investment Committee

The Investment Committee reviews and makes recommendations to the full Board of Trustees regarding the investment policies, strategies and practices of Mayo Clinic.

  • Michael E. Dougherty, Chair
  • Steven J. Buskirk, M.D.
  • Armando Codina
  • Wyatt W. Decker, M.D.
  • Eddie L. Greene, M.D.
  • Charles (Michel) M. Harper, Jr., M.D.
  • Lois E. Krahn, M.D.
  • Ronald L. Olson
  • Aulana L. Peters
  • William C. Rupp, M.D.
  • Eric E. Schmidt, Ph.D.
  • Randolph C. Steer, M.D., Ph.D.
  • Diana L. Taylor
  • Harry N. Hoffman, Secretary*
  • Jeffrey W. Bolton*
  • Chris W. Gade*
  • Paul A. Gorman*
  • John H. Noseworthy, M.D.*

* = Non-member, ex-officio or staff

Investment Committee Charter (PDF)

Dec. 10, 2014